reviewEuropean Heart JournalFeb 18, 2015HYBRID OA

Statin-associated muscle symptoms: impact on statin therapy—European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management

Amsterdam UMC Location University of Amsterdam · Hartford Hospital · +29 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

Statin-associated muscle symptoms (SAMS) are one of the principal reasons for statin non-adherence and/or discontinuation, contributing to adverse cardiovascular outcomes. This European Atherosclerosis Society (EAS) Consensus Panel overviews current understanding of the pathophysiology of statin-associated myopathy, and provides guidance for diagnosis and management of SAMS. Statin-associated myopathy, with significant elevation of serum creatine kinase (CK), is a rare but serious side effect of statins, affecting 1 per 1000 to 1 per 10 000 people on standard statin doses. Statin-associated muscle symptoms cover a broader range of clinical presentations, usually with normal or minimally elevated CK levels,…

Citation impact

1,406
total citations
FWCI
143.34
Percentile
100%
References
125
Citations per year

Authors

55

Topics & keywords

Keywords
  • Medicine
  • Statin
  • myalgia
  • Discontinuation
  • Myopathy
  • Internal medicine
  • Atorvastatin
  • Physical therapy
UN Sustainable Development Goals
  • Affordable and clean energy
No related works found for this paper.

Funding